# DESCRIPTION

## BACKGROUND OF THE INVENTION

- relate to glycan analysis
- describe related art
- motivate MALDI-TOF
- limitations of CA-125

## SUMMARY OF THE INVENTION

- introduce glycan analysis method
- motivate reproducibility
- describe MALDI-TOF method
- introduce new processes
- describe sample preparation
- describe glycan loading
- describe MALDI-TOF measurement
- summarize advantages

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

- introduce MALDI-TOF mass spectrometry for glycans analysis
- describe microwave irradiation for enzyme digestion reaction
- detail MALDI-TOF analysis with Plate #2
- summarize enhanced reproducibility of new MALDI-TOF analytical methods
- present specific examples of the invention
- describe glycan mass spectrometry analysis
- outline analytical method of glycans from samples
- detail step (a) of injecting serum samples into Plate #1
- describe step (b) of glycan extraction by enzyme digestion reaction
- detail step (b-1) of denaturing proteins
- describe step (b-2) of treating glycan-releasing enzyme
- outline step (b-3) of separating glycans from proteins
- describe step (c) of preparing Plate #2 for MALDI-TOF mass spectrometry
- describe micro-focus self-condensing plate
- describe pre-spotted micro-focus plate
- explain pre-spotting of matrix material
- describe coating of sample-loading areas with matrix
- describe loading of glycan solutions onto plate
- describe drying process of plate
- describe MALDI-TOF mass spectrometry analysis
- describe analytical method for glycan profiling
- describe application to cancer screening
- describe cancer screening method
- describe method to differentiate benign ovarian tumor patients
- describe determination of tumor-specific glycans
- describe quantitative analysis of glycan mass spectra
- describe establishment of screening standards
- describe screening method for ovarian tumor patients
- summarize advantages of the present invention

### Glycan Analysis from Human Serum

- describe glycan analysis method

### Example 2

- demonstrate glycan analysis from serum of benign ovarian tumor patients and serum from borderline ovarian tumor patients
- identify ovarian tumor markers

### Example 3

- compare traditional method and present invention method for glycan analysis
- demonstrate improved reproducibility of present invention method

### Example 4

- validate reproducibility of glycan analysis for benign ovarian tumor patients and borderline ovarian tumor patients

### Example 5

- divide patients into training and validation sets
- determine cut-off values for each marker peak
- evaluate efficiency of differentiation power of glycan profiling analysis
- validate accuracy of screening standard
- compare results with CA-125
- demonstrate superiority of glycan analysis method
- describe new quantitative analytical methods
- outline high-throughput screening process

